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PhylogenyIn recent years several atypical pestiviruses have been described. Bungowannah virus is the most divergent
virus in this group. Therefore, heterologous complementation was used to clarify the phylogenetic
relationship and to analyze the exchangeability of genome regions encoding structural proteins. Using a
BVDV type 1 backbone, chimeric constructs with substituted envelope proteins Erns, E1 and E2, were
investigated. While all constructs replicated autonomously, infectious high titer chimeric virus could only be
observed after exchanging the complete E1–E2 encoding region. The complementation of E1 and E2 alone
resulted only in replicons. Complementation of BVDV-Erns was only efﬁcient if Bungowannah virus-Erns was
expressed from a bicistronic construct. Our data provide new insights in the compatibility of pestivirus
proteins and demonstrate that heterologous complementation could be useful to characterize new
pestiviruses.Virology, Friedrich-Loefﬂer-
alth, Suedufer 10, D-17493
1.
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Pestiviruses are single-stranded, positive-sense RNA viruses. The
pestivirus genome has a length of about 12.3 kb and contains one
large open reading frame, which is ﬂanked by non-translated regions
(NTR) at the 5′ and 3′ genome ends. One large polyprotein is co- and
post-translationally processed into 12 viral proteins in the following
order: autoprotease (Npro), capsid protein (C), envelope proteins
(Erns, E1, E2) and non-structural proteins (p7, NS2, NS3, NS4A, NS4B,
NS5A, NS5B) (Collett et al., 1991; Donis, 1995; Rümenapf et al., 1993).
The genus Pestivirus within the family Flaviviridae consists of four
approved species, Bovine viral diarrhea virus-1 (BVDV-1) and -2
(BVDV-2), Border disease virus (BDV) and Classical swine fever virus
(CSFV) (Fauquet and Fargette, 2005). Besides, a tentative ﬁfth species
is represented by an atypical pestivirus isolated from a giraffe
(Plowright, 1969). The classiﬁcation of the classical pestiviruses to
date is mainly based on the host species. While the natural host of
CSFV is pigs, natural BDV infections are not restricted to sheep, and
infections of pig, cattle, reindeer, bison and Pyrenean chamois have
been reported (Arnal et al., 2004; Becher et al., 1997, 1999; Cranwell
et al., 2007; Roehe et al., 1992; Vilcek and Belàk, 1996). BVDV shows
also a broad natural host spectrum and has been isolated from cattle,
pigs as well as from domestic and wild ruminants (Nettleton, 1990;
Vilcek and Nettleton, 2006). Besides the classical pestivirus species,several so-called ‘atypical pestiviruses’ have been described and
categorized into three groups (Liu et al., 2009). The ﬁrst group is of
bovine origin, isolated from cattle, buffalo or from contaminated fetal
calf serum (Schirrmeier et al., 2004; Stahl et al., 2007; Stalder et al.,
2005). The second group, non-bovine origin pestiviruses, includes a
pestivirus, isolated from a pronghorn antelope (Vilcek et al., 2005)
and Bungowannah virus identiﬁed in pigs (Kirkland et al., 2007). The
third group comprises isolates of sheep, so-called ‘Tunisian Isolates’
(Thabti et al., 2005).
Molecular phylogenetic analysis allows a precise classiﬁcation of
pestiviruses and is based on nucleotide sequence differences. The
region most frequently used for the detection and classiﬁcation of
pestiviruses is the 5′ NTR (Pellerin et al., 1994). Npro and E2 genes
have also been used for analysis as well (Becher et al., 1997, 1999).
Npro is unique to pestiviruses and had been used for the character-
ization of putative pestivirus species (Becher et al., 1997, 2003; DeMia
et al., 2005, Kirkland et al., 2007). The envelope protein E2 is themajor
antigen and highly variable viral protein, since it is directly interacting
with the host cell and is able to induce high titers of neutralizing
antibodies (Donis et al., 1988; Rümenapf et al., 1991; Thiel et al.,
1991). Based on a dataset combining 5′NTR, Npro and E2 gene regions,
a new proposal for the classiﬁcation of pestiviruses into nine species:
BVDV-1, BVDV-2, BVDV-3 (atypical bovine pestiviruses), pestivirus of
giraffe, CSFV, BDV, Tunisian sheep virus (TSV), Antelope and
Bungowannah, was presented by Liu et al. (2009).
Bungowannah virus is an atypical pestivirus which was identiﬁed
in 2003 in porcine fetuses on a farm in New South Wales, Australia,
following an outbreak of sudden death with myocarditis in 2–3 week
old pigs and a marked increase in the birth of stillborn fetuses
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the failure of its detection by any pan-pestivirus diagnostic method
(ELISA, cross-neutralization, RT-PCR) puts the classiﬁcation into the
genus Pestivirus into question. However, the detection of the Npro and
Erns coding regions, which are unique to pestiviruses, provides evidence
of a pestivirus. Sequence analyses of the 5′ NTR, Npro and E2 regions
(Kirkland et al., 2007) clearly demonstrate that Bungowannah virus is
only distantly related to any deﬁned pestivirus species and to any
atypical pestivirus, and enable this virus to be considered an ‘atypical’
isolate even within the group of ‘atypical pestiviruses’.
For the Npro protein the amino acid similarity of the novel
Bungowannah virus to other pestiviruses is between 50.9% (BVDV
isolate NY-1) and 55.8% (BVDV isolate NY_93_C) and for the E2
protein between 47.6% (atypical pestivirus Pronghorn) and 51.3%
(BVDV 1373, T1802). The nucleotide sequence of the 5′ NTR shows an
identity of only 53.6% (BDV strain X818) to 62.8% (atypical pestivirus
Pronghorn). Due to the overall divergence from other pestiviruses of
37.2% to 52.3% (Kirkland et al., 2007) and the proposed criteria for
classiﬁcation of pestivirus species (Becher et al., 1999), there is some
discussion if Bungowannah virus is a new pestivirus species or even
the ﬁrst member of a new genus within the family Flaviviridae.
Due to genetic and antigenic similarities, pestivirus proteins of
different genotypes and species can be replaced by trans- and cis-
complementation (de Smit et al., 2001; Harada et al., 2000;
Rasmussen et al., 2007; Reimann et al., 2003, 2004, 2010; van Gennip
et al., 2001, 2002; Wehrle et al., 2007; Widjojoatmodjo et al., 2000).
Here, we describe the heterologous complementation of BVDV using
an infectious clone as backbone and Bungowannah virus as donor,
resulting in novel BVDV-based chimeric pestivirus constructs,
expressing Bungowannah virus-Erns, -E1, -E2, or -E1E2, respectively.Fig. 1. Overview of the genome structure of the parental full-length cDNA clone pA/BVDV (
BVDV CP7 structural protein region and blank boxes indicate the non-structural protein regio
and the hatched box shows the substituted HoBi virus-E2 protein. Arrows highlight the subs
the stop codon and the circle the start codon, respectively. Lines at the left and right endsThe atypical pestivirus ‘HoBi’ was included in the studies to illustrate
that the closer the phylogenetic relationship is, the more successful
the complementation could be.
Results
Construction of the chimeric pestiviruses
Novel chimeric BVDV/Bungowannah virus full-length clones were
constructed on the basis of the infectious cDNA clone pA/BVDV (Meyers
et al., 1996), in which the genomic regions encoding the envelope
proteins Erns, E1 and E2 of the cytopathogenic BVDV strain CP7 were
replaced by that of Bungowannah virus (pA/CP7_Erns-Bungo, pA/
CP7_Erns-Bungo_ΔA, pA/CP7_Erns-Bungo_bi, pA/CP7_E1-Bungo, pA/
CP7_E2-Bungo, pA/CP7_E1E2-Bungo). In addition, a chimeric BVDV/
HoBi virus full-length clone (pA/CP7_E2-HoBi) was generated, in which
the E2-encoding region of BVDV strain CP7 was substituted with the
corresponding region of the so-called “HoBi” virus (Fig. 1). The
constructs pA/CP7_Erns-Bungo and pA/CP7_Erns-Bungo_ΔA differ in
one nucleotide triplet coding for an alanine at the BVDV-E1 N-terminal
region. CP7_Erns-Bungo_bi is a bicistronic construct in which Bungo-
wannah virus-Erns and BVDV-E1 genes are separated by a heterologous
IRES sequence (Fig. 1). This construct allows the expression of Erns and
E1 without proteolytic cleavage between both proteins.
Recovery of BVDV/atypical pestivirus chimeras
In vitro-transcribed RNAs of the full-length BVDVCP7 and of the full-
length chimeric constructs were transfected into KOP-R cells. All RNAs
were able to replicate autonomously as shown by immunoﬂuorescenceMeyers et al., 1996) and the generated chimeric constructs. Shaded boxes indicate the
n. Black colored boxes represent the substituted Bungowannah virus structural proteins
tituted proteins. Horizontal loop region demonstrates the EMCV-IRES; the star indicates
demonstrate NTRs.
115M. Richter et al. / Virology 418 (2011) 113–122(IF) staining with NS3-, Erns- and E2-speciﬁc mabs at 72 h post-
transfection (p.t.) (Fig. 2A). However, there were differences in the
quantity and staining intensity of IF-positive cells. After transfection ofFig. 2. (A) IF analysis of KOP-R cells transfected with in vitro-transcribed RNA of BVDV CP7 o
was analyzed by IF staining using the mab C16 (anti-NS3), WB210 (anti-BVDV-Erns) and the
speciﬁc mab C16, but cells could not be stained with BVDV-Erns- or -E2-speciﬁc mabs if these
of some cross reactivity of the BVDV-E2-mab-mix with HoBi virus-E2, CP7_E2-HoBi RNA-tra
with transfection supernatants and serial passage of the chimeric viruses in bovine KOP-R ce
NS3 expression was analyzed by IF staining using the NS3-speciﬁc mab C16. The chimeric
propagated in KOP-R cells. In contrast, only a few CP7_Erns-Bungo_ΔA-infected cells could b
until passage 2. (C) IF analysis of transfection supernatants and serial passage of the resc
cells were transfectedwithRNAofBVDVCP7orof the chimeric constructs, supernatantswereha
mab C16 at 72 h p.i. infectious virus could be detected and a CPE could be observed.CP7_E1-Bungo- and CP7_E2-Bungo-RNA only single BVDV protein
expressing cells could be detected. The intensity of NS3-speciﬁc
immunostaining of KOP-R cells transfected with CP7_Erns-Bungo-,r the chimeric constructs. At 72 h p.t. expression of the BVDV proteins NS3, Erns and E2
BVDV-E2-mab-mix. RNA-transfected cells could be stained by using the pan-pestivirus-
proteins had been substituted with the respective Bungowannah virus proteins. Because
nsfected cells were positive in the IF staining. (B) IF analysis of KOP-R cells inoculated
lls. Supernatants were harvested at 72 h p.t. and inoculated into KOP-R cells. At 72 h p.i.
viruses vCP7_Erns-Bungo_bi, vCP7_E1E2-Bungo and vCP7_E2-HoBi could be efﬁciently
e detected in the ﬁrst passage and CP7_Erns-Bungo-infected cells were only detectable
ued viruses, vCP7, vCP7_E1E2-Bungo and vCP7_E2-HoBi in porcine SK-6 cells. KOP-R
rvested72 hp.t., and inoculated into SK-6 cell cultures. By IF stainingusing theNS3-speciﬁc
Fig. 2 (continued).
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CP7_E2-HoBi-RNA was comparable to cells transfected with CP7-RNA,
andmore than 95% of the transfected cells reactedwith theNS3-speciﬁc
mab (Fig. 2A). By using the mab WB210 (anti-BVDV-Erns) and an E2-
speciﬁc mab-mix (anti-BVDV-E2), the identity of the Bungowannah
virus-Erns- and -E2-chimeric constructs could be demonstrated, since
Bungowannah virus-Erns and -E2 were not reactive with the respective
BVDV mabs. In contrast, E2 protein of HoBi virus showed some cross-reactivity with anti-BVDV-E2 (Fig. 2A), but failed to react with the
BVDV-E2-speciﬁc mab WB215 (data not shown).
In order to examine, whether the heterologous complementation
of BVDV proteins by Bungowannah virus or HoBi virus proteins
resulted in the production of infectious virus progeny, supernatants of
transfected KOP-R cells were sampled at 72 h p.t. and inoculated into
KOP-R cells. Chimeric viruses vCP7_E1E2-Bungo and vCP7_E2-HoBi
could be propagated most efﬁciently (Fig. 2B). In contrast, infectious
Table 1
Primer set used for plasmid construction.





















a Overlaps that facilitate restriction enzyme digestion are in italics.
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CP7_E1-Bungo- and CP7_E2-Bungo-RNA transfected cells. vCP7_Erns-
Bungo virus showed a severe growth defect and could not be passaged
more than twice in KOP-R cells. vCP7_Erns-Bungo_bi showed also a
growth defect, but could be passagedmore efﬁciently than vCP7_Erns-
Bungo (Fig. 2B).
Inﬂuence of the heterologous complementation on the in vitro-host cell
tropism
In order to investigate, whether the heterologous complementa-
tion affected the host cell tropism, infectious viruses were passaged
and growth-kinetics experiments were done in KOP-R and SK-6 cells
(Table 2). The chimeric viruses vCP7_Erns-Bungo_bi, vCP7_E1E2-
Bungo and vCP7_E2-HoBi could be propagated in KOP-R cells, but to a
different degree (Fig. 2B). In SK-6 cells, infectious virus could be
detected only from supernatants of KOP-R cells transfected with CP7-
RNA and RNA of the constructs pA/CP7_E1E2-Bungo and pA/CP7_E2-
HoBi (Fig. 2C). Infectious virus progeny could not be recovered from
SK-6 cells inoculated with supernatants of KOP-R cells transfected
with RNA of the constructs pA/CP7_Erns-Bungo, pA/CP7_Erns-Bungo_bi,
pA/CP7_E1-Bungo and pA/CP7_E2-Bungo, respectively (data not
shown).
In addition, virus stocks of the 3rd (vCP7_Erns-Bungo_bi) or 4th
(vCP7_E1E2-Bungo, vCP7_E2-HoBi) passage of the rescued viruses in
KOP-R cells were used for further in vitro-characterization by growth
kinetics. In KOP-R cells, the multistep growth curves indicated, thatTable 2
Veriﬁcation of replication and passaging by immunostaining using KOP-R and SK-6 cells.








∅= no BVDV-speciﬁc immunoﬂuorescence.
+ = positive NS3-speciﬁc IF signal.
n.d. = not done.
a KOP-R cells were transfected with in vitro-synthesized RNA and IF stained for NS3-exp
b KOP-R cells were inoculated with supernatants of the second passage and stained by u
c SK-6 cells were inoculated with supernatants of transfected KOP-R cells. Cells were immboth, CP7 and Bungowannah virus replicated efﬁciently and at 72 h
post-infection (p.i.) virus titers of 105.5 TCID50/ml (CP7) and
105.0 TCID50/ml (Bungowannah virus) could be observed (Fig. 4A).
Interestingly, vCP7_E1E2-Bungo replicated more efﬁciently in KOP-R
cells compared to parental CP7 and about 10-fold higher virus titers at
72 h p.i. (106.6 TCID50/ml) could be determined (Fig. 4A). In contrast,
vCP7_Erns-Bungo_bi showed a growth defect and virus titers of only
102.2 TCID50/ml at 72 h p.i. were observed. In SK-6 cells, only
Bungowannah virus, CP7 and vCP7_E1E2-Bungo were able to
replicate. However, due to the host cell tropism of BVDV, CP7 showed
a markedly reduced virus growth in SK-6 cells, and only low virus
titers of about 102.0 TCID50/ml at 72 h p.i. could be detected (Fig. 4B).
Multistep growth curves in SK-6 cells demonstrated a mixed
phenotype for the chimeric vCP7_E1E2-Bungo with a decreased
virus growth compared to parental Bungowannah virus, but a
markedly (more than 1000-fold) more efﬁcient virus growth
compared to the parental BVDV CP7 backbone. At 72 h p.i. virus titers
of about 106.0 TCID5/ml were observed. The highest virus titers could
be determined in SK-6 cells infected with Bungowannah virus
(107.6 TCID50/ml).
Western blot analysis
Since the generation of a viable Bungowannah virus-Erns chimera
was very difﬁcult, the expression and processing of the Bungowannah
virus-Erns protein in the different constructs were studied byWestern








ression after 72 h p.t.
sing the NS3-speciﬁc mab C16 at 72 h p.i.
unostained with mab C16 at 72 h p.i.
Fig. 3. (A)Western blot analysis of PK15 cells infectedwith Bungowannah virus or KOP-R cells transfectedwith the parental full-length RNA of CP7 or RNA of the BVDV/Bungowannah
virus chimeric constructs CP7_Erns-Bungo, CP7_Erns-Bungo_ΔAand CP7_Erns-Bungo_bi using a Bungowannah virus-Erns-speciﬁc rabbit antiserum (1:2000) under reducing conditions.
Cells were harvested and lysed at 72 h p.t. or 96 h p.i. Bungowannah virus-Erns could be detected in lysates infected with Bungowannah virus or transfected with RNA of the
Bungowannah virus-Erns expressing constructs CP7_Erns-Bungo, CP7_Erns-Bungo_ΔA and CP7_Erns-Bungo_bi. BVDV-Erns failed to react with the Bungowannah virus-Erns-speciﬁc
rabbit antiserum. In contrast to Bungowannah virus-infected cells and cells transfected with RNA of CP7_Erns-Bungo_bi, in lysates of cells transfected with CP7_Erns-Bungo- and
CP7_Erns-Bungo_ΔA-RNA a prominent Erns–E1 protein band could be observed. Mock-transfected KOP-R cells and mock-infected PK15 cells were used as negative controls.
(B) Western blot analysis of BSR-T7 cells transfected with pCITE_SgErnsE1E2Bungo using a Bungowannah virus-Erns-speciﬁc rabbit antiserum (1:1000) under reducing conditions.
Cells were harvested and lysed at 24 h p.t. Bungowannah virus-Erns could be detected with a molecular weight of about 38 kDa. Mock-transfected BSR-T7 cells were used as negative
control.
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nization of rabbits with bacterial expressed Bungowannah virus-Erns
proteins. Using this rabbit antiserum in cells infected with Bungo-
wannah virus or transfected with RNA of the constructs pA/CP7_Erns-
Bungo, pA/CP7_Erns-Bungo_ΔA, pA/CP7_Erns-Bungo_bi or transfected
with pCITE_SgErnsE1E2Bungo, a Bungowannah virus-speciﬁc Erns
protein with a molecular weight of about 38 kDa could be detected
(Figs. 3A and B). In contrast to lysates of cells infected with wild-type
Bungowannah virus or transfected with RNA of the bicistronic
construct pA/CP7_Erns-Bungo_bi, a prominent additional Erns-E1-
speciﬁc protein band was visible in lysates transfected with
CP7_Erns-Bungo- or CP7_Erns-Bungo_ΔA-RNA (Fig. 3A). Even after
overexpression of Bungowannah virus-Erns,-E1 and-E2 in BSR-T7 cells
transfected with pCITE_SgErnsE1E2Bungo, no Erns-E1-protein was de-tectable (Fig. 3B). Interestingly, in CP7_Erns-Bungo_ΔA-RNA-transfected
cells Erns could be detected mainly as an Erns-E1 protein, while free Erns
protein was only visible as a very faint band (Fig. 3A).
Discussion
Pestivirus species are genetically closely related and share
common molecular, biochemical and morphological characteristics.
Studies on the exchangeability of pestivirus proteins have been
considerably facilitated by reverse genetics systems (Donis, 1995;
Meyers et al., 1996) and several BVDV/CSFV chimeric pestiviruses
with substituted Erns, E2 or E1E2 proteins (Reimann et al., 2004, 2010;
van Gennip et al., 2001) have been generated. Here, we investigated
the heterologous complementation of the envelope proteins Erns, E1
Fig. 4. Multistep growth curves of chimeric viruses vCP7_Erns-Bungo_bi (▲),
vCP7_E1E2-Bungo (●), the parental BVDV CP7 (■) and the donor Bungowannah
virus (□) in KOP-R cells (A) and SK-6 cells (B). Conﬂuent monolayers of KOP-R or SK-6
cells were infected at a MOI of 0.01. Supernatants were titrated at 0, 8, 24, 48 and 72 h
after inoculation. Virus titers are given as TCID50/ml in log10 steps.
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proteins of the most divergent atypical pestivirus Bungowannah (pA/
CP7_Erns-Bungo, pA/CP7_Erns-Bungo_ΔA, pA/CP7_Erns-Bungo_bi, pA/
CP7_E1-Bungo, pA/CP7_E2-Bungo, pA/CP7_E1E2-Bungo), and fur-
thermore the substitution of BVDV CP7-E2 with the E2 protein of
the atypical HoBi virus (CP7_E2-HoBi). We wanted to analyze, if the
heterologous complementation would result in the generation of
viable virus progeny, and how the exchanges would inﬂuence ﬁtness,
growth characteristics and host cell tropism.
Therefore, chimeric cDNAs were constructed on the basis of the
infectious full-length clone pA/BVDV (Meyers et al., 1996). Transfec-
tion of in vitro-transcribed RNA of all chimeric constructs resulted in
autonomous RNA replication, but viable virus progeny could not be
generated in all cases. Since the BVDV backbone and the donor
Bungowannah virus were isolated from different species, the
generation of viable chimeric pestiviruses was investigated by
passaging the supernatants of transfected cells both on bovine KOP-
R cells and porcine SK-6 cells. vCP7_E1E2-Bungo, with a combined
substitution of the envelope proteins E1 and E2, could be recovered
from both cell lines and high titers were determined in both KOP-R
(106.6 TCID50/ml) and SK-6 cells (106.0 TCID50/ml), while generation
of chimeric viruses with an exchanged single envelope protein E1 or
E2 (vCP7_E1-Bungo, vCP7_E2-Bungo) failed. This is most likely due to
the incompatibility of the respective envelope proteins, resulting in an
inefﬁcient formation of the essential E1–E2 heterodimeric envelope
protein complex. It had been shown that both, E1 and E2, are
necessary to mediate entry of pseudotyped retroviruses into porcine
cells (Wang et al., 2004). Our results also suggest that the E1–E2
heterodimer is the functional form for infectious pestivirus virionsincluding the tested chimera. In addition, misfolding of the viral
glycoproteins causes an inhibition of pestiviral morphogenesis and
formation of infectious virions (Branza-Nichita et al., 2001; Ronecker
et al., 2008). In chimeras with single substitutions of E1 and E2
heterodimerizationmay be hampered because the E1 protein of BVDV
CP7 and Bungowannah virus differs in the number of cysteine
residues (BVDV CP7-E1: 6 cysteines, Bungowannah virus-E1: 3
cysteines), which are important for stabilization of pestivirus E1–E2
heterodimers by disulﬁde bonds (Weiland et al., 1990). Nevertheless,
E2 of the also atypical HoBi virus, which is less divergent from BVDV,
allowed the heterologous complementation of BVDV-E2, and an
infectious chimeric pestivirus vCP7_E2-HoBi could be easily rescued.
Maybe HoBi virus-E2 was able to interact efﬁciently with BVDV-E1,
because E1 proteins of both viruses contain six cysteines. Besides the
number of cysteine residues available for disulﬁde bonds, the amino
acid sequence homology might be important for an efﬁcient
complementation. Based on amino acid sequence data of the E2
protein, homologies of about 61% between BVDV CP7-E2 and HoBi
virus-E2 and homologies of ≤45% between E1 (45%) and E2 (42%) of
BVDV and Bungowannah virus, respectively, may be relevant. In
addition, the amino acid sequence homology between E2 proteins of
BVDV CP7 and CSFV Alfort 187 (59%) as well as between BVDV CP7
and BDV Gifhorn (60%) is markedly higher and a viable BVDV/CSFV
chimera as well as a viable BVDV/BDV chimera has been described
previously (CP7_E2gif; Rasmussen et al., 2007; CP7_E2alf; Reimann
et al., 2004).
The construction of a viable CP7/Bungowannah virus-Erns chimera
was complex. The initially constructed chimera vCP7_Erns-Bungo
showed a severe growth defect, and could be passaged only twice in
KOP-R cells, and virus growth was not supported in SK-6 cells.
Western blot analyses showed a chimeric Erns–E1 protein in cells
transfected with CP7_Erns-Bungo-RNA. Previous studies have demon-
strated the existence of an Erns–E1 protein in cells transfected with
BVDV constructs and showed that cleavage of Erns and E1 is essential
for the generation of infectious BVDV and can be abolished by a single
amino acid substitution in the C-terminal part of the Erns protein
(Wegelt et al., 2009). Surprisingly, in Bungowannah virus infected
cells no Erns–E1 protein could be detected. Even after overexpression
of Bungowannah virus envelope proteins in a pCITE-2a(+) system,
we were not able to detect any Erns–E1 protein. Therefore, we assume
a minor role of the Erns–E1 protein in the Bungowannah virus life
cycle. Thus, the expression of a chimeric Erns–E1 protein in vCP7_Erns-
Bungo infected cells obviously adversely affected virus replication.
This difference in the processing of Erns and E1 is most likely
attributed to the composition of the signalase cleavage site. In the
BVDV polyprotein, the cleavage site between Erns and E1 is composed
of two alanines in contrast to one alanine and one serine in the
Bungowannah virus polyprotein. Therefore, we generated a second
Erns-chimeric construct pA/CP7_Erns-Bungo_ΔA by deletion of one
alanine in the BVDV-E1 coding region to generate a Bungowannah
virus-like cleavage site. But also this chimera was defective in virus
replication and could be passaged in KOP-R cells only for one round.
The third Erns chimeric construct, pA/CP7_Erns-Bungo_bi, allowed the
expression of Bungowannah virus-Erns and CP7-E1 independently
from proteolytic cleavage between these two proteins and could be
passaged in KOP-R cells several times. But this chimera also showed a
growth defect compared to the parental virus CP7 and reached only
low virus titers of about 102.2 TCID50/ml at 72 h p.i. Both constructs
partially support our hypothesis about the role of the proteolytic
cleavage between Erns and E1 in the chimeric construct. However, the
low efﬁciency of the heterologous complementation may also be
caused by the low sequence homology or by differences in the
secondary structure of Bungowannah virus- and CP7-Erns. Probably
due to twomissing N-glycosylation sites, the intracellularly detectable
Bungowannah virus-Erns protein has a signiﬁcant lower molecular
weight of about 38 kDa compared to about 48 kDa of other
120 M. Richter et al. / Virology 418 (2011) 113–122pestiviruses (Donis et al., 1988), and an artifact due to the use of an
antiserum generated against a non-glycosylated Erns-protein
expressed in Escherichia coli (E. coli) seems very unlikely. The Erns-
based amino acid sequence data show a clearly lower homology of
only 58% compared to e.g. BVDV CP7 and BDV Gifhorn (79%) and
BVDV CP7 and CSFV Alfort (76%). However, the most striking
difference to CP7 and other pestiviruses is a deletion of seven amino
acids within the membrane anchor region of Bungowannah virus-Erns
(Kirkland et al., unpublished) which has not been reported for any
pestivirus so far. This is quite astonishing, since previous studies
demonstrated that the integrity of the Erns membrane anchor is
important for the recovery of infectious virus (Tews and Meyers,
2007). In further studies our chimeric constructs will be used to
identify regions of the structural proteins that could be critical for
protein interactions.
Since Bungowannah viruswas isolated from pigs, the virus showed
a predilection for porcine cells and could be propagated in PK15 cells
(Kirkland et al., 2007). Furthermore, virus replication in bovine testis
and lamb testis cell cultures was detectable. Here we could show that
also bovine cells were fully susceptible and supported growth of
Bungowannah virus. However, about 100-fold higher virus titers
could be determined in porcine SK-6 cells compared to bovine KOP-R
cells. Previous studies with pestivirus chimeras showed, that in vitro
the host cell tropism is fully determined by the envelope protein E2.
So, the exchange of BVDV CP7-E2 by CSFV-E2 and BDV-E2,
respectively, resulted in a marked change of in vitro-host range of
the chimeric virus compared to the parental BVDV (Liang et al., 2003;
Rasmussen et al., 2007; Reimann et al., 2004) and very closely
resembled that of the E2 donor CSFV and BDV. Therefore we expected
that the chimera vCP7_E1E2-Bungo would replicate only in porcine
cells efﬁciently. Interestingly, vCP7_E1E2-Bungo could be passaged
both in bovine and porcine cells and the differences in the growth
kinetics were only marginal.
In contrast to pestivirus E2 it had been shown that Erns has no or
only a minor impact on the host cell tropism (de Smit et al., 2001; van
Gennip et al., 2001). In conformity to these studies, the substitution of
BVDV-Erns with Bungowannah virus-Erns (vCP7_Erns-Bungo_bi) did
not result in any change of the cell tropism and this chimera could
replicate in KOP-R cells only. Nevertheless, because of the special
sequence features, the role of Bungowannah virus-Erns in the virus
replication circle is still unclear and has to be further investigated.
Our approach to use heterologous complementation of pesti-
viruses seems also to be relevant for characterization and analysis of
the phylogenetic relatedness of pestivirus isolates. Consistent with
the conserved characteristics of pestivirus genomes and proteins,
chimeric pestiviruses with exchanged envelope proteins of closely
related pestiviruses can be complemented more efﬁciently than more
distantly related pestiviruses. The failure of BVDV/Bungowannah
virus chimeras with substituted single genes encoding the proteins
Erns, E1 and E2 to efﬁciently replicate, or perhaps not replicate at all, in
bovine and porcine cell cultures, is consistent with Bungowannah
virus being more genetically remote from BVDV-1 than the atypical
HoBi virus and the other pestivirus species, BVDV-2, CSFV and BDV,
which were able to complement BVDV-1 proteins efﬁciently.
However, there was efﬁcient complementation with E1E2 and some
complementation with Erns, providing evidence to strongly support
the inclusion of Bungowannah virus as a member of the genus
Pestivirus. Up to now, it had not been shown whether viral proteins
even from other genera or virus families might be manipulated to
yield an infectious hybrid in this system, which could be interesting
i.e. for non-cultivatable human viruses. Indeed, Nam et al. (2001)
constructed a chimeric hepatitis C virus (HCV)/BVDV genome by
replacing the BVDV structural proteins with core, E1 and E2 genes of
HCV, but no infectious chimeric virus could be generated. Although
high levels of HCV structural proteins were expressed in human and
bovine cells following transfection with chimeric RNA, the chimericgenomewas only packaged in bovine cells persistently infected with a
non-cytopathic BVD helper-virus. The generated pseudovirions could
be neutralized only by a BVDV-speciﬁc antiserum but not by a HCV-
speciﬁc antiserum.
In our studies we could demonstrate the compatibility of BVDV
and Bungowannah virus envelope proteins and their inﬂuence on the
host cell tropism. Since Bungowannah virus and the E1E2 chimera
could be efﬁciently propagated in both, bovine and porcine cells, we
hypothesize that natural Bungowannah virus infections may not be
restricted to pigs. Perhaps Bungowannah virus has had an origin in a
wildlife species and later adapted to pigs. In ongoing experiments we
will further study the in vivo- and in vitro-host range of Bungowannah
virus compared to other pestiviruses.
Materials and methods
Cells and viruses
KOP-R cells [RIE244, Collection of Cell Lines in Veterinary
Medicine, Friedrich-Loefﬂer-Institut, Insel Riems, Germany (CCLV)],
a diploid bovine esophageal cell line, PK15 porcine kidney cells
(PK15/51, CCLV), SK-6 swine kidney cells (RIE262, CCLV) and BSR-T7
cells (RIE583, Buchholz et al., 1999, CCLV) were grown in Dulbecco's
Modiﬁed Eagle Medium (DMEM) supplemented with 10% BVDV free
fetal calf serum at 37 °C in a humidiﬁed atmosphere with 5% CO2.
Bungowannah virus (Kirkland et al., 2007) was provided from the
Elizabeth Macarthur Agriculture Institute, New South Wales Depart-
ment of Primary Industries, Australia and was propagated in PK15
cells. D32/00_‘HoBi’ was obtained from the National Reference
Laboratory for BVDV (Friedrich-Loefﬂer-Institut, Insel Riems,
Germany).
Immunoﬂuorescence (IF) analysis
For IF analysis, transfected or infected cells were ﬁxed with 4%
paraformaldehyde (MP Biomedicals) on ice for 15 min, and permea-
bilized for 7 min with 0.01% digitonin in PBS at room temperature
(staining of NS3) or ﬁxed/permeabilized for 5 min using 80% acetone
(staining of E2 and Erns) followed by reaction with the antibodies of
interest. These included the pan-pestivirus NS3-speciﬁc mab C16
(Institute of Virology, Tierärztliche Hochschule Hannover, Germany),
the BVDV-E2-speciﬁc mab-mix (CA1/2; CA34/1/2; CA3/2/22; Institute
of Virology, Tierärztliche Hochschule Hannover, Germany) and the
BVDV-Erns-speciﬁc mab WB210 (CVL Weybridge). As secondary
antibody a goat anti-mouse mab (Invitrogen) was used. For detection
of Bungowannah virus proteins, heat-ﬁxed cells were incubated with
a swine polyclonal Bungowannah virus antiserum for 1 h followed by
incubation with a FITC-labeled anti-swine-IgG (Dessau, Germany).
Generation of the Bungowannah virus-Erns antiserum
The Bungowannah virus-Erns gene was ampliﬁed from the
synthetic ORF Bungo_C-E2mod, containing the sequence of the
Bungowannah virus structural proteins (Geneart AG, Regensburg,
Germany) with the Expand High Fidelity PCR System (Roche) using
the primers BungoErns_NcoI and BungoErns _XbaI (Table 1). The PCR
fragment was cleaved with NcoI and XbaI and ligated into the NcoI/
XbaI-digested vector pBAD/gIIIA (Invitrogen). The resulting plasmid
was cultivated in bacteria [E. coli strain TOP 10, Invitrogen] and
protein expression was initiated by addition of L-arabinose. The
recombinant Bungowannah virus-Erns protein was puriﬁed under
denaturing conditions using the Ni-NTA Fast Start Kit (Qiagen). Two
9-week-old rabbits were immunized each with 1 ml puriﬁed
recombinant Bungowannah virus-Erns proteins in combination with
Polygen as adjuvant (MVP Laboratories, Inc.). After seven immuniza-
tions the ﬁnal antisera were collected.
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Cell lysates were boiled at 95 °C for 2 min. Proteins were separated
by 10% SDS-PAGE, and subsequently transferred onto a nitrocellulose
membrane (Schleicher & Schüll). The membrane was incubated with
the rabbit polyclonal Bungowannah virus-Erns antiserum [diluted
1:1000 to 1:2000 in Tris-buffered saline with 0.1% Tween 20 (TBS-T)
containing 2.5% low-fat milk]. As secondary antibody a horseradish-
peroxidase conjugated anti-rabbit antibody (Dianova; 1:20000 in
TBS-T) was used. The membrane was incubated with SuperSignal®-
West Pico Chemiluminescent detection reagent (Pierce) and visual-
ized in a ChemoCam Western Blot Imaging System (Intas Science
Imaging Instruments GmbH).
Polymerase chain reaction and sequencing
For PCR a PTC-200 Thermal Cycler (MJ Research, Inc.) was used
and primers for PCR and sequencing were custom synthesized
(biomers.net GmbH, Ulm, Germany). DNA-based ampliﬁcation was
done by using the Expand High Fidelity PCR System, Phusion™ High
Fidelity DNA polymerase (Finnzymes) or PfuUltra™ High Fidelity
DNA polymerase (Stratagene) according to the supplier's protocols.
For RT-PCR, total RNA of virus-infected cells was extracted using
TRIZOL reagent (Invitrogen) and cDNA was produced using the
OneStep RT-PCR Kit (Qiagen). Sequencing was carried out using the
Big Dye® Terminator v1.1 Cycle sequencing Kit (Applied Biosystems).
Nucleotide sequences were read with an automatic sequencer (3130
Genetic Analyzer, Applied Biosystems) and analyzed using the
Genetics Computer Group software version 11.1 (Accelrys Inc., San
Diego, USA).
In vitro-transcription, transfection and virus rescue
In vitro-transcription was done with the RiboMax Large Scale RNA
Production System (Promega). RNA (1 to 5 μg) was transfected into
KOP-R cells by using the Gene Pulser Xcell Electroporation System
(Bio-Rad). For virus recovery, cell culture supernatants of vCP7_Erns-
Bungo_bi-, vCP7_E1E2-Bungo-, vCP7- and Bungowannah virus-infected
cells were harvested at 72 h p.i. and infectious titers were determined
for virus stocks as well as for growth-kinetics experiments. Virus stocks
were prepared by passaging the viruses on KOP-R or PK15 cells and
the identity of the recombinant viruses was conﬁrmed by sequencing.
For plasmid transfection in BSR-T7 cells SuperFect transfection
reagent (Qiagen) was used. Cells were lysed for Western blot
experiments 24 h p.t.
Growth-kinetics
For in vitro-growth-kinetics analyses KOP-R or SK-6 cells were
inoculated with the various viruses at a MOI=0.01 TCID50/ml.
Supernatants were collected at 0, 8, 24, 48 and 72 h p.i. The virus
was detected by IF staining at 72 h p.i. and the titers were calculated
and expressed as a 50% tissue culture infective dose per ml (TCID50/
ml).
Plasmid constructs
Plasmids were ampliﬁed in E. coli DH10B™ cells (Invitrogen) and
the cloning procedure was performed according to standard protocols
or by a modiﬁed target-primed plasmid ampliﬁcation method (Geiser
et al., 2001; Stech et al., 2008). Plasmid DNA was puriﬁed by Qiagen
Plasmid Mini or Midi Kits (Qiagen). The primers used for PCR are
given in Table 1. The plasmid Bungo_C-E2mod was used as template
for the generation of megaprimers. The chimeric cDNA constructs
were generated in a BVDV CP7 backbone (pA/BVDV, Meyers et al.,
1996) by replacing the genomic regions encoding for the structuralproteins with the corresponding regions of Bungowannah virus and
HoBi virus, respectively. Thus, pA/BVDV served as template for the
Fusion PCRs. For construction of pA/CP7_Erns-Bungo a PCR fragment of
plasmid Bungo_C-E2mod was ampliﬁed by using the primers
Ph_CP7_Erns-Bungo_F and Ph_CP7_Erns-Bungo_R. The puriﬁed PCR
fragment served as a megaprimer in the Fusion PCR with Phusion™
High Fidelity DNA polymerase. The chimeric cDNA constructs pA/
CP7_Erns-Bungo_ΔA, pA/CP7_E1-Bungo, pA/CP7_E2-Bungo and pA/
CP7_E1E2-Bungo (Fig. 1) had been constructed in the same way by
using the appropriate primers (Table 1). The plasmid pA/CP7_E2-HoBi
was constructed by ampliﬁcation of a megaprimer by using plasmid
pGEM_E2-HoBi as DNA template and primers Ph_CP7_E2-HoBi_F and
Ph_CP7_E2-HoBi_R followed by Fusion PCR. For the construction of
the plasmid pA/CP7_Erns-Bungo_bi CP7 sequences had to be subcloned
into the plasmid vector pCITE-2a(+) (Novagen). Therefore, a PCR
fragment was ampliﬁed from the plasmid pA/BVDV with the Expand
High Fidelity PCR System using the primers SgErns_NcoI and
SgErns_NheI_XbaI, cleaved with NcoI and XbaI and ligated into the
NcoI/XbaI-digested pCITE-2a(+) resulting in the plasmid pCITE_Sg.
Unique NheI and XbaI sites of plasmid pCITE_Sg were used for the
insertion of a PCR fragment, which was generated from pA/BVDVwith
the primers E1_NheI and 3804_XbaI, resulting in plasmid pCITE_SgE1-
3804. For further cloning, three restriction recognition sites were
removed using the QuikChange® II XL Site-Directed Mutagenesis Kit
(Stratagene). From this plasmid a PCR fragment was ampliﬁed by
using the primers IRES_Acc65I and 3804_Acc65I, cleaved with Acc65I
and ligated into the Acc65I-digested plasmid CP7ΔErns_1179_MluI
(Wegelt et al., 2009). Into the resulting plasmid CP7ΔErns_bi, the
Bungowannah virus-Erns gene, which was ampliﬁed from the
synthetic ORF Bungo_C-E2mod using the primers Ph_CP7_Erns-
Bungo_F and Ph_Bungo-Erns_bi_R was inserted by Fusion PCR. For
overexpression studies the plasmid pCITE_SgErnsE1E2Bungo was
constructed. Therefore, the genomic region encoding the signal
sequence upstream of the Bungowannah virus-Erns and the Bungowan-
nah virus envelope proteins Erns, E1 and E2 was ampliﬁed from the
synthetic ORF Bungo_C-E2mod by using the Expand High Fidelity PCR
System with primers BungoSgErns_NcoI and BungoE2_XbaI (Table 1).
The PCR fragment was cleaved with NcoI and XbaI and ligated into the
NcoI/XbaI-digested vector pCITE-2a(+). The resulting frame-shift was
repaired with the QuikChange® II XL Site-Directed Mutagenesis Kit.
Further information about cloning procedures is available under
request.
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